Biographical Sketch
Carol Burke, MD, completed medical school at the Ohio State University College of Medicine and Public Health, and residency at Riverside Methodist Hospital, both in Columbus, Ohio. Dr. Burke performed her Gastroenterology Fellowship at the Cleveland Clinic in 1993 and has been on the professional staff since that time.
Dr. Burke enjoys patient care, medical education and research, particularly in the area of colorectal polyp and cancer prevention. She is internationally known for her work in the polyposis syndromes and is the Director of the Center for colon polyp and cancer prevention and has been awarded research grants from the National Cancer Institute, American College of Gastroenterology, and Industry to name a few, to study the effects of chemopreventive agents on the prevention of intestinal neoplasia.
She is the co-director of the multi-disciplinary Hereditary Cancer Clinic and provides consultations including risk assessment, and endoscopic evaluation and treatment for individuals with a hereditary predisposition to cancer.
She is the author of numerous peer reviewed manuscripts, abstracts, book chapters, and is a frequent reviewer for many digestive disease journals.
She has served as a committee member, or chairperson in the American College of Gastroenterology, American Society of Gastrointestinal Endoscopy and is currently on the Board of Trustees for the American College of Gastroenterology.
Specialty Interests
chemoprevention of colorectal neoplasia, colonic neoplasia, colorectal cancer screening strategies, hereditary polyposis and nonpolyposis colorectal cancer, Colon cancer prevention, colon cancer screening, Colonoscopy
Awards & Honors
Dr. Burke is on the Board of Trustees of the American College of Gastroenterology.
Dr. Burke is a member of the National Medical Honor Society, Alpha Omega Alpha
Industry Relationships
Cleveland Clinic physicians and scientists may collaborate
with the pharmaceutical or medical device industries
to help develop medical breakthroughs or provide
medical education about recent trends. The
collaborations are reviewed as part of the Cleveland
Clinic’s procedures. The Cleveland Clinic publicly
discloses payments to its physicians and scientists
for speaking and consulting of
$5,000 or more per year, and any equity, royalties,
and fiduciary relationships in companies with which
they collaborate. In publicly disclosing this
information, the Cleveland Clinic tries to provide
information as accurately as possible about its
doctors’ connections with industry and those of their
immediate family members. As of 7/31/2008, Dr.
Burke has reported the financial relationships
with the companies listed below. Patients should feel
free to contact their doctor about any of the
relationships and how the relationships are overseen
by the Cleveland Clinic. To learn more about the
Cleveland Clinic’s policies on collaborations with
industry and innovation management, go to
our Integrity in Innovation page.
Consulting. Dr. Burke receives fees of $5,000 or more per year as a paid consultant or speaker for the following companies:
Takeda
